ErlySign, a healthtech startup, raised Rs 16 crore ($1.8 million) from Ashish Kacholia in its pre-Series A round.
Clinical trials, obtaining CDSCO (Central Drugs Standard Control Organization) approvals, and launching ErlySign’s oral cancer detection kit will all be funded with the proceeds.
Shubhendra Singh Thakur and Deovrat Begde founded ErlySign in 2019 with the goal of creating solutions for the early detection of oral cancer.
The startup also says it has the first salivary biomarker-based test in India that can detect precancerous conditions long before symptoms show up.
Looking ahead, ErlySign intends to identify several cancer types in 15–20 minutes using a single saliva sample and CRISPR miRNA-based testing technology.
